16 August 2020: Articles
Renal Transplant Recipient with Concurrent COVID-19 and Pneumonia Treated with Trimethoprim/Sulfamethoxazole Leading to Acute Kidney Injury: A Therapeutic Dilemma
Diagnostic / therapeutic accidents, Unusual setting of medical care, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis), Rare coexistence of disease or pathology
Mohamed A. Mohamed B , Jasleen Kaur C , Farah Wani B , Asim Kichloo A , Ravinder Bhanot A*DOI: 10.12659/AJCR.926464
Am J Case Rep 2020; 21:e926464
Table 1. Lab results during the clinical course of the patient.
| Admission | Day 3* | Day 5** | Day 7 | Day 8*** | Day 11 | Reference value | |
|---|---|---|---|---|---|---|---|
| Creatinine (mg/dL) | 0.7 | 0.8 | 1.0 | 2.1 | 3.4 | 2.8 | 0.5–1.3 |
| BUN (mg/dL) | 18 | 34 | 43 | 64 | 73 | 56 | 7–26 |
| GFR (ml/min/1.73 m) | >60 | >60 | >60 | 27 | 18 | 29 | >60 |
| Arterial pH | 7.34 | 7.25 | 7.29 | 7.22 | 7.19 | 7.19 | 7.35–7.45 |
| Arterial PO2 (mmHg) | 108 | 75 | 84 | 76 | 92 | 67 | 80–108 |
| FiO2 (in%) | 100 | 80 | 80 | 90 | 100 | 100 | Up to 100 |
| * Day3: Sputum cultures re-sent; ** Day 5: Cultures positive for , Sulfamethoxazole/Trimethoprim (TMP/SMX) initiated; *** Day 8: Dialysis initiated. | |||||||